NDC 49502-378

ERMEZA

Levothyroxine Sodium

ERMEZA is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Specialty L.p.. The primary component is Levothyroxine Sodium.

• Product ID: 49502-378_1654f193-aab5-41f7-a038-146382f63dab
• NDC: 49502-378
• Product Type: Human Prescription Drug
• Proprietary Name: ERMEZA
• Generic Name: Levothyroxine Sodium
• Dosage Form: Solution
• Route of Administration: ORAL
• Marketing Start Date: 2022-12-14
• Marketing Category: NDA /
• Application Number: NDA215809
• Labeler Name: Mylan Specialty L.P.
• Substance Name: LEVOTHYROXINE SODIUM
• Active Ingredient Strength: 30 ug/mL
• Pharm Classes: Thyroxine [CS], l-Thyroxine [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2024-12-31

Packaging

NDC 49502-378-15

1 BOTTLE, GLASS in 1 CARTON (49502-378-15) > 150 mL in 1 BOTTLE, GLASS

• Marketing Start Date: 2022-12-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ERMEZA" or generic name "Levothyroxine Sodium"

NDC	Brand Name	Generic Name
0074-3727	Synthroid	Levothyroxine Sodium
0074-4341	Synthroid	Levothyroxine Sodium
0074-4552	Synthroid	Levothyroxine Sodium
0074-5182	Synthroid	Levothyroxine Sodium
0074-6594	Synthroid	Levothyroxine Sodium
0074-6624	Synthroid	Levothyroxine Sodium
0074-7068	Synthroid	Levothyroxine Sodium
0074-7069	Synthroid	Levothyroxine Sodium